Swiss National Bank Boosts Stock Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Swiss National Bank lifted its holdings in shares of Aspen Aerogels, Inc. (NYSE:ASPN) by 1.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 128,800 shares of the construction company’s stock after acquiring an additional 2,400 shares during the quarter. Swiss National Bank’s holdings in Aspen Aerogels were worth $1,530,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Kovitz Investment Group Partners LLC bought a new stake in shares of Aspen Aerogels during the third quarter valued at about $263,000. Morse Asset Management Inc purchased a new stake in Aspen Aerogels in the 3rd quarter worth approximately $264,000. AlphaQuest LLC boosted its holdings in Aspen Aerogels by 54.0% in the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock valued at $135,000 after purchasing an additional 3,998 shares during the period. Maven Securities LTD purchased a new position in shares of Aspen Aerogels during the 3rd quarter valued at $415,000. Finally, Journey Strategic Wealth LLC purchased a new position in shares of Aspen Aerogels during the 4th quarter valued at $178,000. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Trading Down 5.1 %

Shares of ASPN opened at $6.60 on Friday. Aspen Aerogels, Inc. has a fifty-two week low of $6.55 and a fifty-two week high of $33.15. The firm has a market cap of $541.48 million, a price-to-earnings ratio of 41.22 and a beta of 2.28. The firm has a 50 day moving average price of $9.04 and a 200-day moving average price of $14.77. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. As a group, equities research analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the company. B. Riley dropped their price objective on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a research note on Wednesday, February 19th. Barclays dropped their price target on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research report on Wednesday, February 19th. TD Cowen upgraded shares of Aspen Aerogels to a “strong-buy” rating in a research report on Tuesday, March 11th. Seaport Res Ptn lowered shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 12th. Finally, Roth Mkm decreased their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Friday, February 14th. One analyst has rated the stock with a sell rating, one has issued a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Aspen Aerogels presently has an average rating of “Moderate Buy” and a consensus price target of $19.11.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.